Analysis of small cell lung cancer (SCLC) patients (Pts) treated on cancer therapy evaluation program (CTEP)-sponsored phase I trials: 1992-2012.

被引：0
|
作者：
Forde, Patrick M.
Hooker, Craig M.
Rubinstein, Larry
Hann, Christine L.
Harris, Pamela Jo
机构：
[1] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA
[2] Biometr Res Branch, Bethesda, MD USA
[3] NCI, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.7524
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7524
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase II study of combination therapy with liposomal doxorubicin and carboplatin (CBDCA) in patients (pts) with previously untreated small cell lung cancer (SCLC).
    Vorobiof, DA
    Rapoport, BL
    Slabber, CF
    Alberts, AS
    Uys, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 690S - 690S
  • [22] A retrospective evaluation of metformin usage in patients with small cell lung cancer (SCLC).
    Mellema, Wouter W.
    Aarts, Mieke J.
    Van Herk-Sukel, Myrthe P. P.
    Smit, Egbert F.
    CANCER RESEARCH, 2013, 73 (08)
  • [23] Late phase II trials of topotecan (T) for relapsed small cell lung cancer (SCLC)
    Nishiwaki, Y
    Negoro, S
    Watanabe, K
    Fukuoka, M
    Niitani, H
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S253 - S253
  • [24] Dermatologic toxicities of 3,517 solid tumor patients on phase I clinical trials of the National Institutes of Health Cancer Therapy Evaluation Program (CTEP).
    Drilon, Alexander E.
    Eaton, Anne
    Schindler, Katja
    Gounder, Mrinal M.
    Smith, Gary L.
    Vulih, Diana
    Harris, Pamela Jo
    Spriggs, David R.
    Ivy, Percy
    Iasonos, Alexia
    Lacouture, Mario E.
    Hyman, David Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] Phase I open-label study of cediranib plus etoposide (E) and cisplatin (P) as first-line therapy for patients (pts) with small cell lung cancer (SCLC) or lung neuroendocrine cancer (NEC)
    Heymach, J.
    Glisson, B. S.
    Doebele, R. C.
    Huang, C.
    Gandara, D. R.
    Le Seoullier, S.
    Marotti, M. A.
    Camidge, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Pregnancies in subjects on oncology clinical trials: Analysis from the Cancer Therapy Evaluation Program (CTEP) database.
    Mittra, Arjun
    Murray, James
    Takebe, Naoko
    Chen, Alice P.
    Ivy, S. Percy
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Weekly topotecan-gemcitabine for pretreated small cell lung cancer (SCLC) patients (pts): A phase II study.
    Domine, M.
    Gonzalez-Larriba, J. L.
    Lopez-Vilarino, J.
    Alfonso, R.
    Leon, A.
    Puente, J.
    Casado-Echarren, V.
    Rodriguez, L.
    Rubio, G.
    Lobo, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Relationship between hemoglobin (Hb) level drop and outcome of patients (pts) treated for small cell lung cancer (SCLC): Our retrospective analysis.
    Gianni, L
    Genestreti, G
    Tassinari, D
    Papi, M
    Imola, M
    Rudnas, B
    Monticelli, G
    Oliverio, G
    Pasquini, E
    Ravaioli, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 683S - 683S
  • [29] VALIDATION AND COMPARISON OF PUBLISHED PROGNOSTIC CLASSIFICATIONS FOR SURVIVAL IN PATIENTS (PTS) WITH SMALL CELL LUNG CANCER (SCLC)
    Paesmans, M. N.
    Lafitte, J. J.
    Lecomte, J. N.
    Berghmans, T.
    Efremidis, A. N.
    Meert, A. P.
    Leclercq, N. N.
    Sculier, J.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S104 - S104
  • [30] Analysis of long term survival patients with small cell lung cancer (SCLC)
    Bychkov, MB
    Gorbunova, VA
    Orel, NF
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 263 - 266
12345